Advanced or Recurrent Endometrial Cancer Clinical Trial
0 vistas
• 07/09/23
0
0
Empotrar
administrator
Suscriptores
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios